|
|
|
 |
|
| FDA Advisory Committee Recommmends FDA Approval of Herceptin for Treatment of Breast Cancer |
|
|
1998/09/03 -The Food and Drug Administration's (FDA) Oncology Drugs Advisory Committee has recommended (September 3, 1998) that the FDA approve the drug Herceptin, a biologically engineered antibody that has shown promise in treating women with advanced breast cancer. The FDA is not bound by the committee's recommendations, but usually follows them. A final decision is expected in November.
More information on the current availability of Herceptin can be obtained by calling the manufacturer, Genentech, at 888-777-4464.
Joann Schellenbach
National Director Media Relations
American Cancer Society
212-382-2169
jschelle@cancer.org
|
|
|
|
|
